PhytoHealth CEO Angel Lee Recognized for Driving the Advancement of World's First Prescription Drug for Cancer-Related Fatigue

RegulatoryapprovedPG2Positive

AI Analysis

Summary

PhytoHealth Corporation CEO Angel Lee was recognized for advancing PG2, Taiwan's first approved botanical new drug for cancer-related fatigue. The recognition highlights the company's clinical work in developing this prescription drug treatment.

Outcome Details

Taiwan's first approved botanical new drug

Importance:4/10

Sentiment:

0.60

regulatory approvalTaiwanbotanical drugcancer-related fatigueleadership recognition

Related Companies

$TRAX $WHEN

Read the original article

Published by PR Newswire Biotech on October 2, 2026 8:11 AM

Read Original